Lab Launch has worked with over 35 life sciences startups since 2015. We select companies based on their people--specifically we look for folks who are conscientious, cooperative, and hard working. These qualities add to our community, making Lab Launch a collaborative, enjoyable place to develop top-notch biotechnology. It turns out that good community members are pretty great at starting companies. Many of our current and former members have raised significant funding and over 94% are still in business.
AcuraStem has developed a break-through precision medicine platform incorporating patient stem cells and advanced machine learning technology. We have leveraged this platform to identify a novel ALS target and preclinical lead candidate which we are working to advance to the clinic.
Quantum Screening Inc. is a biotechnology company engaged in developing saliva-based point of care, non-invasive, low-cost screening and detection tests to create revolutionary improvements in human health. Quantum’s founder, Uttam Sinha, MS, MD, FACS, and his team have spent the last 15 years developing a point-of-care test for oral cancer that will allow physicians to give conclusive results to their patients in a matter of minutes.
Founded in 1976, StatLab Medical Products is a leading developer and manufacturer of cost- effective histology, cytology and immunohistochemistry diagnostic supplies. StatLab offers 1,750 of the most commonly purchased diagnostic supplies used by independent and hospital-based anatomic pathology laboratories. Over 3,000 anatomic pathology laboratories across the United States rely on StatLab to satisfy their diagnostic supply requirements.
TCRCure's dedication to immune cell therapy is supported by four pillars of advanced technology: TCR repertoire analysis and big data mining; high throughput antigen-specific TCR cloning; T cell genetic engineering; and GMP-level, industry scale vector production and immune cell manufacturing. Based on these platforms, TCRCure has established four major product pipelines: generalizable TCR-T; personalized TCR-T; long-lived and suppression-resilient CAR-T and TCR-T; and clinical immune monitoring
Pathways to Stem Cell Science is a non-profit institute and leading provider of real-world training in molecular cell biology, stem cell biology and regenerative medicine. We offer innovative programs for students of all ages to learn hands-on science with human stem cells.
Laboratory for Advanced Medicine Inc. develops leading edge non-invasive, non-toxic technologies focusing on early detection and intervention of cancer, especially in stage 0 and 1. LAM ® headquartered in the United States with offices in United States (Los Angeles and Indianapolis) and China (Beijing, shanghai, and Tianjin), is founded and managed by a group of accomplished business leader, scientists, and physicians.
Cell Care Therapeutics is developing novel cellular therapies and delivery systems to permit the cost efficient and long-term treatment of inflammatory and degenerative diseases.
Aukera, Inc. is an early stage biotechnology company focused on the production of the vault nanoparticle, a hollow protein shell designed by Nature. Using proprietary technology, we rapidly manufacture highly pure vault nanoparticles for research and delivery of therapeutic molecules.